Corona Remedies P/E Ratio
Corona Remedies (CORONA) P/E ratio is 53.75 (High), EPS (TTM) ₹30.27, current price ₹1777.30 on NSE vs historical average P/E of 51.35 (100.0th percentile) — Very High - High growth expectations or significantly overvalued. Analyse CORONA institutional holdings to track promoter, FII and institutional holdings.
Current Valuation Metrics
Valuation Signal
Sector Context
Earnings Breakdown (TTM)
CORONA P/E Ratio — Valuation Signal & Historical Context
Corona Remedies P/E 53.75 vs historical average 51.35, range 51.35–51.35 — signal: Overvalued. Browse CORONA cash flow statement for revenue, profit, balance sheet and cash flow data.
- Stock appears overvalued with PE of 53.75, suggesting caution for new investments
Corona Remedies P/E Ratio Historical Trend
CORONA annual price-to-earnings ratio — 1 years, EPS and year-end price. Current P/E 53.75 vs historical average 51.35. For live price, revenue and the complete fundamental profile, see Corona Remedies stock price NSE.
CORONA Historical P/E Ratio — EPS, Year-End Price & Valuation
Corona Remedies annual P/E ratio, EPS (₹), year-end price and valuation category on NSE.
| Year | P/E Ratio | EPS (₹) | Year-end Price (₹) | Exchange | Valuation |
|---|---|---|---|---|---|
| 2025 | 51.35 | 28.01 | ₹1438.40 | NSE | High |
CORONA vs Healthcare Peers — P/E Ratio Comparison
Corona Remedies P/E 53.75 vs Healthcare average 54.5, median 27.76 — range 1.0–1029.66.
| Company | Symbol | P/E Ratio | Market Cap (₹ Cr) | Valuation |
|---|---|---|---|---|
| Welcure Drugs & Pharmace… | WELCURE | 1.0 | ₹36 | Low |
| Murae Organisor | MURAE | 2.86 | ₹41 | Low |
| Phaarmasia | PHRMASI | 3.45 | ₹61 | Low |
| Ind Swift Laboratories | INDSWFTLAB | 4.89 | ₹1,201 | Low |
| Amwill Health Care | AMWILL | 6.51 | ₹71 | Low |
| Mono Pharmacare | MONOPHARMA | 7.1 | ₹22 | Low |
| Brooks Laboratories | BROOKS | 7.31 | ₹140 | Low |
| Medicamen Organics | MEDIORG | 7.67 | ₹30 | Low |
| Zenith Drugs | ZENITHDRUG | 7.69 | ₹68 | Low |
| Shelter Pharma | SHELTER | 7.82 | ₹54 | Low |